Skip to main content
. 2012 Sep 28;303(11):L967–L977. doi: 10.1152/ajplung.00144.2011

Fig. 7.

Fig. 7.

IGF-I decreases LPS-induced lung injury. A: ELISA measurement showing that IGF-I is present at higher levels in MSC-CdM compared with Fib-CdM. *P < 0.05 control; #P < 0.01. B–D: treatment with recombinant mouse IGF-I (rIGF-I; n = 5) significantly attenuated BALF cells influx (B), lung permeability (C), and lung injury score (D) compared with LPS-DMEM (n = 5). *P < 0.05 control vs. LPS groups; #P < 0.05 LPS-rIGF-I vs. LPS-DMEM. E: representative images of lungs from experimental animals. Size bar: 130 μm.